Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Baxter
Medtronic
Colorcon
Cantor Fitzgerald
Federal Trade Commission
Dow
Deloitte

Generated: October 23, 2018

DrugPatentWatch Database Preview

BINOSTO Drug Profile

« Back to Dashboard

Which patents cover Binosto, and when can generic versions of Binosto launch?

Binosto is a drug marketed by Mission Pharma and is included in one NDA. There are two patents protecting this drug.

The generic ingredient in BINOSTO is alendronate sodium. There are twenty-five drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the alendronate sodium profile page.

Drug patent expirations by year for BINOSTO
Pharmacology for BINOSTO
Ingredient-typeDiphosphonates
Drug ClassBisphosphonate
Medical Subject Heading (MeSH) Categories for BINOSTO
Synonyms for BINOSTO
(4-Amino-1-hydroxy-1-phosphonobutyl)phosphonic Acid Monosodium Salt
(4-Amino-1-hydroxybutylidene)bisphosphonic acid monosodium salt
129318-43-0
4-AMINO-1-HYDROXY-1-PHOSPHONOBUTYL PHOSPHONIC ACID,MONOSODIUM
4-AMINO-1-HYDROXYBUTYLIDENE-1,1-BISPHOSPHONIC ACID MONOSODIUM SALT
4-Amino-1-hydroxybutylidine-1,1-bisphosphonate
4988K7X26P
A805927
AB10152
AC1Q1W16
AHBuBP
AHButBP
AKOS015895071
Alend
ALENDRONATE SODIUM
Alendronate sodium anhydrous
Alendronate, Sodium Salt
Alendronate, Sodium, Trihydrate
Alendronic Acid Monosodium Salt
Alendronic acid sodium salt
ALENDRONIC ACID, SODIUM
Alendronic acid, Sodium aldendronate
Almerol
AN-32438
API0001401
Avalent
BB_SC-02791
BB_SC-2791
BG0020
Bonalon
C4H12NNaO7P2
CAKRAHQRJGUPIG-UHFFFAOYSA-M
CCG-220631
CHEMBL675
EX-101
Fosamac
Fosamax
G-704650
GTH-42
GTH-42J
GTH-42V
GTH-42W
HMS3604I12
Hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate (Na+)
I06-0478
Indrol
J-005667
KS-1028
L-670452
LS-106423
MER-103
MFCD00868112
MFCD01861681
MK 217
MK-0217
MK-217
Monosodium (4-Amino-1-hydroxy-1-phosphonobutyl)phosphonate
Monosodium alendronate
NeoBon
Onclast
Osteovan
P,P'-(4-Amino-1-hydroxybutylidene)bis-phosphonic acid monosodium salt
PHOSPHONATE, (4-AMINO-1-HYDROXY-1-PHOSPHONOBUTYL)-, SODIUM SALT
Phosphonic acid, (4-amino-1-hydroxybutylidene)bis-, monosodium salt
SC-22170
SCHEMBL328770
sodium (4-amino-1-hydroxy-1-phosphono-butyl)-hydroxy-phosphinate
sodium (4-amino-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate
sodium (4-azanyl-1-oxidanyl-1-phosphono-butyl)-oxidanyl-phosphinate
SODIUM ALDENDRONATE
Sodium alendronate
sodium alendronate(1-)
sodium hydrogen(4-amino-1-hydroxy-1-phosphonobutyl)phosphonate
Steovess
Teiroc
UNII-4988K7X26P
Y-8756

US Patents and Regulatory Information for BINOSTO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mission Pharma BINOSTO alendronate sodium TABLET, EFFERVESCENT;ORAL 202344-001 Mar 12, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Mission Pharma BINOSTO alendronate sodium TABLET, EFFERVESCENT;ORAL 202344-001 Mar 12, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for BINOSTO

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Baxter
Medtronic
Colorcon
Cantor Fitzgerald
Federal Trade Commission
Dow
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.